Medicare's 2025 reimbursement cuts are significantly impacting orthopedic surgeons, driving practice consolidation and raising concerns over future Medicare participation and patient access in musculoskeletal care.

CMS announces the ACCESS Model, a 10-year voluntary value-based payment program to expand tech-enabled care for Medicare chronic condition patients, linking payments to health outcomes.

The AMA endorses CMS's ACCESS Model, promoting technology-enabled care for chronic conditions in Medicare patients, aiming to improve outcomes and modernize disease management.

Study reveals geographic and sociodemographic factors driving epilepsy incidence among older U.S. adults, highlighting regional disparities and associated risk factors.

CMS sets 2027 maximum fair prices for 15 high-cost Medicare drugs, cutting costs by up to 85% and saving $12 billion annually under Inflation Reduction Act measures.

Zing Health sues HHS and CMS over improper Medicare Part D termination and star rating methodology disputes, claiming significant financial and reputational damages.

U.S. health insurance networks are contracting due to increased medical costs and decreased government funding, impacting payer strategies and provider networks.

CMS releases 2027 Medicare Advantage and Part D proposed rule focusing on Star Ratings adjustments, regulatory burden reduction, and program spending projections.

CMS introduces the ACCESS payment model to provide Medicare beneficiaries with chronic conditions greater access to technology-driven care, shifting from fee-for-service to outcome-based payments.

Discover critical factors driving retirees to reconsider Medicare Advantage plans in 2025, including network constraints, pre-authorization challenges, and coverage gaps compared to traditional Medicare and Medigap options.